http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111228247-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c6ca70f5b7659ebab80fb979cb91356
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
filingDate 2019-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdb81b997bf5cd6de2ef0f98c7d03cbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aee686492a73eedef4a1ffdabe8ff5f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b299b0494b072a65473388153c2f94b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfd2ba77f891851ceb2e2d0d546ed6d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d97368ee404808ee621192d5c7ec7893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e40b78900e0d0d702905ea4d37b25ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95b190b9ffdf33214269b242cc07732d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f14602289e9aec0100f4d605a43166e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc6b6ec6749f191f32b4df39b4ec2701
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed4ba8adfd3989f75782a17a7fb105f6
publicationDate 2020-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111228247-A
titleOfInvention A kind of medicine containing benzylidene acetone for treating hydatid disease and preparation method thereof
abstract The invention relates to a benzylidene acetone-containing medicine for treating hydatid disease and a preparation method thereof. The active component of the medicine is benzylidene acetone. The dosage forms of this medicine include emulsion, tablet, powder, pill, granule, capsule and the like. At the same time, it also relates to the preparation method of the above-mentioned drug emulsion. The benzylidene acetone-containing medicine of the present invention can be used for treating hydatid disease, and the active component of the medicine, benzylidene acetone, can effectively reduce the number and weight of vesicles in combination with an animal model of hydatid disease at the in vivo level. Has a good therapeutic effect.
priorityDate 2019-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190012556-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110114354-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0226713-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103717586-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101239929-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201302760-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102325767-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID6211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519125
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID6210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409778579
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID6210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588820
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414878880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15909
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID6211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID575870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2082

Total number of triples: 47.